Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 27, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000012.pdf 0001708138-21-000012.xls
Jan 15, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-004699.pdf 0001104659-21-004699.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 11, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-002614.pdf 0001104659-21-002614.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 05, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-000538.pdf 0001104659-21-000538.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-21-000904.pdf 0001104659-21-000904.xls
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-21-000901.pdf 0001104659-21-000901.xls
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-21-000001.pdf 0001237899-21-000001.xls
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000006.pdf 0001708138-21-000006.xls
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000007.pdf 0001708138-21-000007.xls
Jan 05, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-21-000002.pdf 0001237899-21-000002.xls

Data provided by Kaleidoscope.

Investors & Media